Send mail to Author

An open-label trial of 12-week Simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with hepatitis C Virus (HCV) genotype 1 (GT1) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __     ___     _____       ___      ______    ______  
 | |/ //   / _ \\  |  __ \\    / _ \\   /_   _//  /_   _// 
 | ' //   / //\ \\ | |  \ ||  | / \ ||  `-| |,-    -| ||-  
 | . \\  |  ___  ||| |__/ ||  | \_/ ||    | ||     _| ||_  
 |_|\_\\ |_||  |_|||_____//    \___//     |_||    /_____// 
 `-` --` `-`   `-`  -----`     `---`      `-`'    `-----`
 


Back to frontdoor view

OPUS4 Logo